PLK1 and hepatocellular carcinoma: In conclusion, our findings demonstrated that genetical or pharmacological PLK1 inhibition selectively induced TERT downregulation, cell cycle arrest and apoptosis in HCC cells harbouring TERT promoter mutations through Smad3.